We use essential cookies (authentication, your saved goals/stack) by default. With your permission we'll also enable privacy-respecting analytics (Vercel Web Analytics, anonymous load-time metrics) and error-replay diagnostics (Sentry — DOM snapshots only when an error fires) so we can fix bugs faster. Learn more about cookies
Topical cosmetic ingredient — not a dietary supplement
Bakuchiol is a topical cosmetic ingredient, not a supplement you take internally and not a drug. It is sold legally in skincare products to affect the appearance of skin (such as wrinkles). The evidence below comes mostly from small, often industry-funded studies of topical application, so treat the effect sizes cautiously. This page is for transparency and education, not a recommendation.
What the evidence says
Most Bakuchiol studies are mechanism or observational rather than RCTs that measure a clinical effect — keep findings provisional.
Most evidence is from mixed-quality randomised trials published 2014–2025 with a typical study size of 44 participants.
Based on 6 studies · 3 RCTs · 209 total participants
Confidence
ModerateBy outcome
Bakuchiol has an evidence score of 4/10 — emerging evidence based on 6 indexed studies. A plant-derived topical skincare active marketed as a gentler 'retinol alternative' — a leave-on cosmetic applied to the skin, NOT ingested. Bakuchiol is a meroterpene purified from the seeds of Psoralea corylifolia (babchi). Despite no structural resemblance to retinoids, gene-expression studies show it behaves like a functional retinol analogue, switching on collagen genes. The headline evidence is one good 12-week randomized, double-blind trial (44 people) in which bakuchiol matched retinol for reducing wrinkles and pigmentation while causing less stinging and scaling. The honest framing: that single 44-person study carries most of the weight. The rest of the human evidence is thin — small, often unblinded or uncontrolled trials, several testing bakuchiol only inside multi-ingredient products, and many industry-linked; a 2024 systematic review judged the body of evidence high-risk-of-bias and not poolable. These are cosmetic appearance outcomes, not health outcomes. (Note: purified topical bakuchiol is distinct from oral Psoralea corylifolia, which carries hepatotoxicity and phototoxic-furocoumarin concerns.) Representative study: PMID 38564402.
Practical, evidence-based guides that cover Bakuchiol.
Explore: Best supplements for Skin, Hair & Beauty
Last reviewed June 2026 · evidence from 6 studies · how we score
This information is for educational purposes only. It is not a substitute for professional medical advice. Always consult a qualified healthcare provider before starting, stopping, or changing any supplement or medication.
Bakuchiol (topical retinol alternative)
A plant-derived topical skincare active marketed as a gentler 'retinol alternative' — a leave-on cosmetic applied to the skin, NOT ingested. Bakuchiol is a meroterpene purified from the seeds of Psoralea corylifolia (babchi). Despite no structural resemblance to retinoids, gene-expression studies show it behaves like a functional retinol analogue, switching on collagen genes. The headline evidence is one good 12-week randomized, double-blind trial (44 people) in which bakuchiol matched retinol for reducing wrinkles and pigmentation while causing less stinging and scaling. The honest framing: that single 44-person study carries most of the weight. The rest of the human evidence is thin — small, often unblinded or uncontrolled trials, several testing bakuchiol only inside multi-ingredient products, and many industry-linked; a 2024 systematic review judged the body of evidence high-risk-of-bias and not poolable. These are cosmetic appearance outcomes, not health outcomes. (Note: purified topical bakuchiol is distinct from oral Psoralea corylifolia, which carries hepatotoxicity and phototoxic-furocoumarin concerns.)
One rigorous head-to-head RCT (n=44) credibly supports 'comparable to retinol with less irritation,' and the mechanism is plausible (retinol-like gene expression), but the overall human evidence is thin — short, small, often uncontrolled or combination-product trials, several industry-linked — and a 2024 systematic review judged it high-risk-of-bias and not meta-analyzable.
Bakuchiol is a meroterpene phenol purified from the seeds of Psoralea corylifolia (babchi), used as a leave-on active in cosmetics and widely marketed as a plant-based 'retinol alternative.' It is a TOPICAL skincare ingredient applied to the skin — not ingested.
The mechanistic story is genuinely interesting: although bakuchiol bears no structural resemblance to retinoids, comparative gene-expression profiling in a full-thickness skin model (Chaudhuri & Bojanowski, 2014) found its effect on the gene-expression profile closely resembled retinol's, including upregulation of type I, III, and IV collagen — hence the description of bakuchiol as a 'functional retinol analogue.' The headline clinical evidence is a single, reasonably rigorous trial: a prospective, randomized, double-blind, 12-week study (Dhaliwal et al., 2019; 44 patients) in which bakuchiol 0.5% twice daily and retinol 0.5% once daily both significantly reduced wrinkle surface area and hyperpigmentation, with no statistically significant difference between them — and retinol users reported more scaling and stinging.
That is the basis for the popular claim that bakuchiol is 'comparable to retinol with less irritation.' Beyond it, the human evidence thins out quickly.
A non-randomized vehicle-controlled study (Lyons et al., 2020; 20 subjects) found bakuchiol significantly improved trichloroacetic-acid-induced post-inflammatory hyperpigmentation versus vehicle, but its effect on acne-induced PIH did not reach significance.
The acne and sensitive-skin data come from combination products: a 111-patient RCT (Poláková et al., 2015) showed adding a bakuchiol-containing complex to adapalene improved acne, and a 34-patient trial (2025) of a bakuchiol + Terminalia chebula serum improved wrinkles and barrier markers — but in both, bakuchiol was only one of several ingredients, so its independent contribution cannot be isolated.
The honest counterweight is decisive: a 2024 systematic review (Fanning et al.) of 15 human bakuchiol trials found twelve were unblinded, open-label, and uncontrolled, ten used combination therapy, and the body of evidence carried a high risk of bias and could not be meta-analyzed.
Much of the supporting work is also industry-linked (the ingredient's commercial developer and cosmetics-company R&D centers).
None of this is a health claim: bakuchiol is a lawful cosmetic whose documented benefit is a modest, retinol-like improvement in the appearance of photoaged skin, with better tolerability than retinol but a much thinner evidence base.
One important safety distinction: purified topical bakuchiol is NOT the same as oral Psoralea corylifolia (Fructus Psoraleae), which has been associated with hepatotoxicity and contains phototoxic furocoumarins — those concerns relate to systemic/herbal use, not the purified topical cosmetic.
It is listed under Beauty & Appearance so it is discoverable, but is sandboxed out of ingestible-supplement stacks and the schedule optimizer; it carries a cosmetic badge and a topical-only disclaimer.
Despite no structural resemblance to retinoids, bakuchiol's effect on the skin gene-expression profile closely mirrors retinol's, including upregulation of type I, III, and IV collagen. This 'functional retinol analogue' activity is the proposed basis for its anti-wrinkle effect — without engaging the retinoid receptors that drive retinol's irritation.
Bakuchiol has antioxidant activity and, in the head-to-head trial, produced significantly less scaling and stinging than retinol. This gentler profile is its main practical selling point over retinoids, particularly for sensitive skin.
Topical cosmetic only. Bakuchiol is typically formulated around 0.5-1% in leave-on serums or creams and applied to clean skin once or twice daily. Unlike retinol it is not photolabile, so it can be used AM or PM, though daily sunscreen is still recommended. There is no oral, injectable, or systemic dose — it is not ingested. This library does not provide an ingestion protocol.
| Form | Type |
|---|---|
| 🧴Leave-on topical serum or cream (0.5-1% purified bakuchiol) | Recommended |
| 💊Combination anti-aging formulas containing bakuchiol | Alternative |
There is no oral or injectable cosmetic form. Purified topical bakuchiol is distinct from oral whole-herb Psoralea corylifolia preparations.
Minimum: 8 weeks
Optimal: 12 weeks
Cycling: Not required
Note: Applied to clean skin once or twice daily. Bakuchiol is photostable (unlike retinol), so AM or PM use is fine; daily broad-spectrum sunscreen is still recommended for any anti-aging routine.
Every documented benefit is a modest improvement in the APPEARANCE of photoaged skin. Bakuchiol is a topical cosmetic, not an ingested supplement, and purified topical bakuchiol is distinct from oral Psoralea corylifolia.
In a 12-week randomized, double-blind trial, bakuchiol significantly reduced wrinkle surface area and hyperpigmentation, with no significant difference from retinol. Most of the anti-wrinkle evidence rests on this single 44-person study.
Bakuchiol caused significantly less facial scaling and stinging than retinol in the head-to-head trial and is generally well tolerated, making it a popular option for sensitive or retinoid-intolerant skin.
A 2024 systematic review found most human bakuchiol trials were unblinded, uncontrolled, or tested bakuchiol inside multi-ingredient products, with high risk of bias. Treat strong marketing claims cautiously.
Purified topical bakuchiol differs from the whole herb Psoralea corylifolia (Fructus Psoraleae), which when taken orally has been linked to liver toxicity and contains phototoxic furocoumarins. Those concerns relate to systemic/herbal use, not the purified topical cosmetic.
Topical bakuchiol has not been formally studied in pregnancy or lactation; although it is not a retinoid, discuss any skincare active with your clinician, especially given its plant (Psoralea) origin.
Often chosen specifically for sensitivity, as it tends to be gentler than retinol; still patch-test before facial use.
Do not equate purified topical bakuchiol with oral Psoralea corylifolia, which carries hepatotoxicity and phototoxic concerns; avoid ingesting babchi preparations.
Bakuchiol is usually well tolerated and is sometimes paired with retinoids, but combining several actives can still irritate sensitive skin. This is a tolerability/formulation consideration, not a systemic drug interaction — it is not ingested.
Tip: Generally gentler than retinol; patch-test and reduce frequency if irritation occurs.
Tip: Discontinue and avoid if an allergic reaction occurs.
The commonly studied dose of Bakuchiol is Topical cosmetic only. Bakuchiol is typically formulated around 0.5-1% in leave-on serums or creams and applied to clean skin once or twice daily. Unlike retinol it is not photolabile, so it can be used AM or PM, though daily sunscreen is still recommended. There is no oral, injectable, or systemic dose — it is not ingested. This library does not provide an ingestion protocol.. Individual needs vary — start at the lower end of the range and adjust based on how you respond.
Timing is flexible for Bakuchiol — consistent daily use matters more than the time of day. Bakuchiol is a leave-on topical with no meal-timing relationship.
Bakuchiol is generally well-tolerated and considered safe for most healthy adults at recommended doses. The most commonly reported side effects are mild local irritation or redness, contact allergic reaction. Use caution if any of these apply to you: For topical (skin) use only — not for ingestion, not for injection; Known allergy or sensitivity to bakuchiol or formulation excipients; Application to broken, irritated, or compromised skin until healed.
Bakuchiol vs retinol vs adapalene vs tretinoin — pick by strength and tolerance, not hype.